Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-19

Clinical Trial Update: Study Of GW823093 In Japanese Subjects With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial update for GW823093 in Japanese adults with Type 2 diabetes mellitus has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GW823093

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2018-03-19